DR. JEROME SEYMOUR TANNENBAUM, M.D., PH.D.
Osteopathic Medicine at Union St, Nashville, TN
License number
Tennessee MD9962
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
511 Union St SUITE 1800, Nashville, TN 37219
Phone
(615) 467-0140
Personal information
See more information about JEROME SEYMOUR TANNENBAUM at radaris.comName
Address
Phone
637 Good Springs Rd, Brentwood, TN 37027
4375 Chickering Ln, Nashville, TN 37215
Professional information
See more information about JEROME SEYMOUR TANNENBAUM at trustoria.com
Chairman And Chief Executive Officer At Sanderling Healthcare, Llc
Chairman And Chief Executive Officer At Sanderling Healthcare, Llc
Position:
Chairman and Chief Executive Officer at Sanderling Healthcare, LLC
Location:
Greater Nashville Area
Industry:
Hospital & Health Care
Work:
Sanderling Healthcare, LLC
- Greater Nashville Area since Feb 2009
-
Chairman and Chief Executive Officer
DSI Holding, Inc.
- Greater Nashville Area Oct 2008 - Apr 2009
-
Chairman of the Board
DSI Renal, Inc
- Greater Nashville Area Apr 2003 - Sep 2008
-
Chairman and CEO
IMRAC Corporation
2000 - 2003
-
Chairman
National Nephrology Associates
- Greater Nashville Area 1998 - 2003
-
Chairman and CEO
Education:
Washington University St Louis - Barnes Hospital Renal Division 1980 - 1982
Fellowship - Nephrology Washington Univ St Louis - Jewish Hospital 1978 - 1980
Residency - Internal Medicine Vanderbilt university Hospital 1977 - 1978
internship - Internal Medicine, internal Medicine Vanderbilt University School of Medicine 1971 - 1976
MD Vanderbilt University 1967 - 1971
BA, Math, Chemistry, Physics
Fellowship - Nephrology Washington Univ St Louis - Jewish Hospital 1978 - 1980
Residency - Internal Medicine Vanderbilt university Hospital 1977 - 1978
internship - Internal Medicine, internal Medicine Vanderbilt University School of Medicine 1971 - 1976
MD Vanderbilt University 1967 - 1971
BA, Math, Chemistry, Physics
Chairman And Ceo At Dsis, Inc.
Chairman And Ceo At Dsis, Inc.
Position:
Chairman and CEO at DSIS, Inc., Chairman at DSI Holding Company, Inc
Location:
Greater Nashville Area
Industry:
Health, Wellness and Fitness
Work:
DSIS, Inc.
-
Chairman and CEO
DSI Holding Company, Inc
since 2003
-
Chairman
IMRAC/National Nephrology Associates
1998 - 2003
-
Chairman
Education:
Vanderbilt University
Dr. Jerome S Tannenbaum - MD (Doctor of Medicine)
Dr. Jerome S Tannenbaum - MD (Doctor of Medicine)
Hospitals:
511 Union St SUITE 1800, Nashville 37219
511 Union St SUITE 1800, Nashville 37219
511 Union St SUITE 1800, Nashville 37219
Education:
Medical Schools
Vanderbilt University School Of Medicine
Graduated: 1976
Vanderbilt University School Of Medicine
Graduated: 1976
Diagnostic Identification, Evaluation And Management Of Polyvascular Disease And Related Conditions
Diagnostic Identification, Evaluation And Management Of Polyvascular Disease And Related Conditions
US Patent:
2012019, Jul 26, 2012
Filed:
May 26, 2010
Appl. No.:
13/322679
Inventors:
Paulita M. LaPlante - Inver Grove Heights MN, US
Daniel J. Bartnik - Eden Prairie MN, US
Rose A. Griffith - Eden Prairie MN, US
Jerome S. Tannenbaum - Nashville TN, US
Daniel J. Bartnik - Eden Prairie MN, US
Rose A. Griffith - Eden Prairie MN, US
Jerome S. Tannenbaum - Nashville TN, US
Assignee:
VASAMED, INC. - Eden Prairie MN
International Classification:
G06Q 50/22
US Classification:
705 2
Abstract:
One aspect of the present invention provides an electronic system accessible via a collaborative subscription service to facilitate improved access and analysis of patient data relevant to Polyvascular disease. In one specific embodiment, the electronic system is used by physicians and health care service providers to aggregate relevant medical data points, as the electronic system provides recommendations and analysis of patient care for specific Polyvascular symptoms and conditions. These data points are collected through appropriate medical devices and are transmitted for storage and access within the operational environment. One embodiment of the service also enables a collaborate environment for communication between various health care providers, professionals, and the patient regarding specific patient conditions. Accordingly, improved diagnosis, treatment, and monitoring of the various conditions related to Polyvascular disease can be deployed for the patient.